sIL-2R plasma levels as a potential marker for progression to vascular complications in patients with type 1 diabetes

被引：0
|
作者：
Keindl, M. [1 ,2 ]
Fedotkina, A. [1 ]
du Plessis, E. [1 ]
Jain, R. [3 ]
Bergum, B. [2 ]
Falhammar, H. [4 ]
Nystrom, T. [4 ]
Catrina, S. -B. [4 ]
Groop, L. [5 ,6 ]
Eliasson, M. [7 ]
Eliasson, B. [8 ]
Nilsson, P. M. [3 ]
Berg, T. J. [9 ]
Appel, S. [2 ]
Lyssenko, V. [1 ,3 ]
机构：
[1] Univ Bergen, Dept Clin Sci, Ctr Diabet Res, Bergen, Norway
[2] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway
[3] Lund Univ, Ctr Diabet, Genom Diabet & Endocrinol, Malmo, Sweden
[4] Karolinska Inst, Stockholm, Sweden
[5] Lund Univ, Dept Clin Sci, Ctr Diabet, Malmo, Sweden
[6] Univ Helsinki, Helsinki, Finland
[7] Umea Univ, Umea, Sweden
[8] Univ Gothenburg, Gothenburg, Sweden
[9] Univ Oslo, Oslo, Norway
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
68
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Is plasma ET-1 a marker of vascular complications in type 2 diabetes mellitus?
    Sármán, B
    Tóth, M
    Kocsis, I
    Somogyi, A
    [J]. DIABETOLOGIA, 1999, 42 : A320 - A320
  • [2] Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia
    Moon, Y
    Kim, Y
    Kim, M
    Lim, J
    Kang, CS
    Kim, W
    Shim, SI
    Chung, NG
    Park, YH
    Min, WS
    Han, K
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2004, 34 (04): : 410 - 415
  • [3] Plasma vWF levels correlate with plasma soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with background retinopathy
    Timuragaoglu, A
    Balci, MK
    Karadogan, I
    Altunbas, H
    Ozturk, F
    Karayalcin, U
    Undar, L
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : PS458 - PS458
  • [4] Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency
    Verwoerd, Anouk
    Vorselaars, Adriane D. M.
    van Moorsel, Coline H. M.
    Bos, Willem Jan W.
    Jan, Heleen van Velzen-Blad
    Grutters, Jan C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (01) : 277 - 280
  • [5] Soluble interleukin 2 receptor (sIL-2R) levels in patients with ocular inflammation
    Papadaki, TG
    Iaccheri, B
    Fiore, T
    Androudi, S
    Thadani, S
    Meniconi, M
    Christen, WG
    Foster, C
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U607 - U607
  • [6] Plasma vWF levels correlate with soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with retinopathy.
    Karayalcin, U
    Timuragaoglu, A
    Balci, MK
    Karadogan, I
    Altunbas, H
    Undar, L
    [J]. DIABETOLOGIA, 1997, 40 : 1549 - 1549
  • [7] Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients
    Chibowska, Maria
    Krasowska, Dorota
    Weglarz, Janusz
    [J]. MEDICAL SCIENCE MONITOR, 2001, 7 (02): : 282 - 288
  • [8] Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation
    Barosi, Giovanni
    Campanelli, Rita
    Catarsi, Paolo
    De Amici, Mara
    Abba, Carlotta
    Viarengo, Gianluca
    Villani, Laura
    Gale, Robert P.
    Rosti, Vittorio
    Massa, Margherita
    [J]. LEUKEMIA RESEARCH, 2020, 90
  • [9] Plasma homocysteine levels and chronic complications in patients with Type 2 diabetes
    Idzior-Walus, B
    Cieslik, G
    Walus, M
    Wozniakiewicz, E
    Fedak, D
    Sieradzki, J
    [J]. DIABETOLOGIA, 2004, 47 : A415 - A415
  • [10] Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
    Jenkins, Alicia J.
    McBride, Jeffrey D.
    Januszewski, Andrzej S.
    Karschimkus, Connie S.
    Zhang, Bin
    O'Neal, David N.
    Nelson, Craig L.
    Chung, Jasmine S.
    Harper, C. Alex
    Lyons, Timothy J.
    Ma, Jian-Xing
    [J]. VASCULAR CELL, 2010, 2
12345